South Wales, Jan. 9 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "INKORZA" on Dec. 17, 2025. The details about the trademark application no. UK00004311835 published in the journal no. 2026/002 (Jan. 9).
With Carpmaels & Ransford LLP as representative, AbbVie Inc. filed the trademark application for the below mentioned good(s)/service(s).
Class 5 : Pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of cancer; pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of oncological diseases, disorders, and conditions.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004311835
Disclaimer: Curated by HT Syndication.
